What is the recommended dosage of Gabapentin (Neurontin) for nerve pain?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Gabapentin Dosing for Nerve Pain

For neuropathic pain, gabapentin should be started at 100-300 mg at bedtime or 100-300 mg three times daily, with gradual titration to 900-3600 mg/day in divided doses over 3-8 weeks. 1, 2, 3

Initial Dosing and Titration

  • Start with 100-300 mg at bedtime or 100-300 mg three times daily 1, 2, 3
  • Increase by 100-300 mg every 1-7 days as tolerated 1, 4
  • Target effective dose range: 900-3600 mg/day in divided doses (typically three times daily) 1, 2, 4
  • Maximum dose should not exceed 3600 mg/day 1, 4

Duration of Treatment Trial

  • An adequate trial requires 3-8 weeks for titration plus 2 weeks at maximum dose to properly evaluate efficacy 1, 3
  • Complete pain relief may take several weeks to achieve optimal effect 2

Dosage Adjustments for Special Populations

  • Elderly patients: Start at lower doses and titrate more slowly 1, 2, 4
  • Renal impairment: Dosage reduction required based on creatinine clearance 1, 2, 4
    • For creatinine clearance 30-59 mL/min: 400-1400 mg/day in divided doses
    • For creatinine clearance 15-29 mL/min: 200-700 mg/day in single daily dose
    • For creatinine clearance <15 mL/min: 100-300 mg/day in single daily dose 4

Efficacy for Different Types of Neuropathic Pain

  • Postherpetic neuralgia: 38% of patients achieve substantial pain relief (≥50% reduction) compared to 21% with placebo 5
  • Diabetic neuropathy: 38% of patients achieve substantial pain relief compared to 21% with placebo 5
  • Doses of 1800-3600 mg/day provide good levels of pain relief for these conditions 5

Side Effects and Monitoring

  • Common side effects include dizziness (19%), somnolence (14%), peripheral edema (7%), and gait disturbance (14%) 5
  • Side effects are typically mild to moderate and often transient, usually subsiding within approximately 10 days from treatment initiation 6
  • Risk of falls or fractures increases with doses ≥600 mg/day (RR 1.35) 7
  • Monitor for altered mental status, especially at higher doses 7

Clinical Pearls

  • Gabapentin has nonlinear pharmacokinetics due to saturable absorption, requiring careful titration 1
  • Dividing the daily dose into three administrations helps minimize peak-related side effects 1, 4
  • The maximum time between doses should not exceed 12 hours 4
  • If using scored tablets (600 mg or 800 mg), unused half-tablets should be taken as the next dose and discarded if not used within 28 days 4
  • If discontinuing gabapentin, taper gradually over at least 1 week to avoid withdrawal symptoms 4

Comparative Efficacy

  • While doses up to 3600 mg/day have been studied, doses above 1800 mg/day may not provide additional benefit for postherpetic neuralgia 4
  • For diabetic neuropathy and other neuropathic pain conditions, doses between 1800-3600 mg/day may be needed for optimal effect 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Gabapentin Dosing Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Gabapentin Dosing and Safety Considerations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Gabapentin for chronic neuropathic pain in adults.

The Cochrane database of systematic reviews, 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.